Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 163

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 163
---
EUDA
HEALTH HOLDINGS LIMITED AND SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

(In
U. S. dollars, unless stated otherwise)

The
following table reconciles Singapore statutory rates to the Company’s effective tax rate:

Schedule
of effective income tax rate

 ─────────────────────────────────────────────────────────────────────────────────
  Singapore statutory income tax rate              17.0        17.0        17.0  
  Tax rate difference outside Singapore (1)         1.7      ( 16.6      ( 14.2  
  Taxable income below exemption threshold          0.0         0.0         0.0  
  Change in valuation allowance                   ( 1.0       ( 0.4       ( 1.9  
  Others (2)                                     ( 17.7         0.0       ( 0.8  
  Effective tax rate                                0.0         0.0         0.1  

  (2)      Others                                                                                                                                     

The
following table sets forth the significant components of the aggregate deferred tax assets and liabilities of the Company as of:

Schedule
of deferred tax assets and liabilities

                                              December                     December 31, 2023                 
                                              31, 2024                                                       
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Deferred Tax Assets                                                                                        
  Valuation allowance for credit losses       $                   411      $                            426  
  Net operating loss carry forwards                           675,460                               544,385  
  Lease liabilities                                            32,849                                20,574  
  Less: valuation allowance *                               ( 676,318                             ( 545,099  
  Total deferred tax assets, net              $                32,402      $                         20,286  
  Deferred Tax Liabilities                                                                                   
  Right of use assets                         $              ( 32,402      $                       ( 20,286  
  Amortization of intangible assets                          ( 76,700                                     -  
  Total deferred tax liabilities                            ( 109,102                              ( 20,286  
  Deferred tax assets/(liabilities), net      $              ( 76,700      $                              -  

  The                                                                                                                 
  valuation allowance on all deferred tax assets increased by $ 131,219 from December 31, 2023 to December 31, 202